Susceptibility for Some Infectious Diseases in Patients With Diabetes: The Key Role of Glycemia

Chávez-Reyes, Jesús; Escárcega‐González, Carlos Enrique; Chavira-Suárez, Erika; León-Buitimea, Ángel; Vázquez-León, Priscila; Morones‐Ramírez, José Rubén; Villalón, Carlos M.; Quintanar‐Stephano, Andrés; Marichal‐Cancino, Bruno A.

doi:10.3389/fpubh.2021.559595

Cited by 89 publications

(55 citation statements)

References 254 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Therefore, hyperglycemia and the immune system can differentially impact the production of inflammatory mediators during microbial infection in diabetic individuals. These changes may not only actively participate in the inflammatory process of DM, accelerating the complications associated with the disease, but may also interfere with the host's defense against microbial infections [ 74 , 75 ].…”

Section: Main Findings and Discussionmentioning

confidence: 99%

Interplay Among the Oral Microbiome, Oral Cavity Conditions, the Host Immune Response, Diabetes Mellitus, and Its Associated-Risk Factors—An Overview

Negrini

Carlos

Duque

et al. 2021

Front. Oral. Health

View full text Add to dashboard Cite

This comprehensive review of the literature aimed to investigate the interplay between the oral microbiome, oral cavity conditions, and host immune response in Diabetes mellitus (DM). Moreover, this review also aimed to investigate how DM related risk factors, such as advanced age, hyperglycemia, hyperlipidemia, obesity, hypertension and polycystic ovary syndrome (PCOS), act in promoting or modifying specific mechanisms that could potentially perpetuate both altered systemic and oral conditions. We found that poorly controlled glycemic index may exert a negative effect on the immune system of affected individuals, leading to a deficient immune response or to an exacerbation of the inflammatory response exacerbating DM-related complications. Hyperglycemia induces alterations in the oral microbiome since poor glycemic control is associated with increased levels and frequencies of periodontal pathogens in the subgingival biofilm of individuals with DM. A bidirectional relationship between periodontal diseases and DM has been suggested: DM patients may have an exaggerated inflammatory response, poor repair and bone resorption that aggravates periodontal disease whereas the increased levels of systemic pro-inflammatory mediators found in individuals affected with periodontal disease exacerbates insulin resistance. SARS-CoV-2 infection may represent an aggravating factor for individuals with DM. Individuals with DM tend to have low salivary flow and a high prevalence of xerostomia, but the association between prevalence/experience of dental caries and DM is still unclear. DM has also been associated to the development of lesions in the oral mucosa, especially potentially malignant ones and those associated with fungal infections. Obesity plays an important role in the induction and progression of DM. Co-affected obese and DM individuals tend to present worse oral health conditions. A decrease in HDL and, an increase in triglycerides bloodstream levels seem to be associated with an increase on the load of periodontopathogens on oral cavity. Moreover, DM may increase the likelihood of halitosis. Prevalence of impaired taste perception and impaired smell recognition tend to be greater in DM patients. An important interplay among oral cavity microbiome, DM, obesity and hypertension has been proposed as the reduction of nitrate into nitrite, in addition to contribute to lowering of blood pressure, reduces oxidative stress and increases insulin secretion, being these effects desirable for the control of obesity and DM. Women with PCOS tend to present a distinct oral microbial composition and an elevated systemic response to selective members of this microbial community, but the association between oral microbiome, PCOS are DM is still unknown. The results of the studies presented in this review suggest the interplay among the oral microbiome, oral cavity conditions, host immune response and DM and some of the DM associated risk factors exist. DM individuals need to be encouraged and motivated for an adequate oral health care. In addition, these results show the importance of adopting multidisciplinary management of DM and of strengthening physicians-dentists relationship focusing on both systemic and on oral cavity conditions of DM patients.

show abstract

Section: Main Findings and Discussionmentioning

confidence: 99%

Interplay Among the Oral Microbiome, Oral Cavity Conditions, the Host Immune Response, Diabetes Mellitus, and Its Associated-Risk Factors—An Overview

Negrini

Carlos

Duque

et al. 2021

Front. Oral. Health

View full text Add to dashboard Cite

show abstract

“…Insulin resistance lies at the key crossroads of metabolic and mitochondrial dysfunction, visceral fat, non-alcoholic fatty liver (NAFL), muscle exercise and weight loss resistance, subclinical inflammation, metabolic syndrome (MetS), overweight, and obesity, and is characterized by epigenetically driven accelerated aging, as Nannini et al [3] reported. Insulin resistance plays a key role in a reduced capability of the immune system to kill pathogens such as viruses and bacteria, as De Rosa et al [4] and Chávez-Reyes et al [5] reported. Vestergaard Jensen et al [6] reported insulin resistance as an important risk factor for community-acquired pneumonia.…”

Section: Introductionmentioning

confidence: 99%

Hepatic-Metabolite-Based Intermittent Fasting Enables a Sustained Reduction in Insulin Resistance in Type 2 Diabetes and Metabolic Syndrome

Rohner¹,

Heiz

Feldhaus³

et al. 2021

Horm Metab Res

View full text Add to dashboard Cite

Insulin resistance is the hallmark of Type 2 Diabetes and is still an unmet medical need. Insulin resistance lies at the crossroads of non-alcoholic fatty liver disease, obesity, weight loss and exercise resistance, heart disease, stroke, depression, and brain health. Insulin resistance is purely nutrition related, with a typical molecular disease food intake pattern. The insulin resistant state is accessible by TyG as the appropriate surrogate marker, which is found to lead the personalized molecular hepatic nutrition system for highly efficient insulin resistance remission. Treating insulin resistance with a molecular nutrition-centered approach shifts the treatment paradigm of Type 2 Diabetes from management to cure. This allows remission within five months, with a high efficiency rate of 85%. With molecular intermittent fasting a very efficient treatment for prediabetes and metabolic syndrome is possible, improving the non-alcoholic fatty liver disease (NAFL) state and enabling the body to lose weight in a sustainable manner.

show abstract

“…As a result, diabetic patients are susceptible to infection and inflammation when exposed to pathogenic bacteria, and their infections cannot be easily cured since diabetic patients have defects in innate and adaptive immunity [65,66]. Furthermore, uncontrolled diabetes elevates the inflammatory response and oxidative stress, exacerbating infection [67].…”

Section: Glucose Metabolism and Gut Microbiotamentioning

confidence: 99%

Sarcopenia Is a Cause and Consequence of Metabolic Dysregulation in Aging Humans: Effects of Gut Dysbiosis, Glucose Dysregulation, Diet and Lifestyle

Daily¹,

Park

2022

Cells

View full text Add to dashboard Cite

Skeletal muscle mass plays a critical role in a healthy lifespan by helping to regulate glucose homeostasis. As seen in sarcopenia, decreased skeletal muscle mass impairs glucose homeostasis, but it may also be caused by glucose dysregulation. Gut microbiota modulates lipopolysaccharide (LPS) production, short-chain fatty acids (SCFA), and various metabolites that affect the host metabolism, including skeletal muscle tissues, and may have a role in the sarcopenia etiology. Here, we aimed to review the relationship between skeletal muscle mass, glucose homeostasis, and gut microbiota, and the effect of consuming probiotics and prebiotics on the development and pathological consequences of sarcopenia in the aging human population. This review includes discussions about the effects of glucose metabolism and gut microbiota on skeletal muscle mass and sarcopenia and the interaction of dietary intake, physical activity, and gut microbiome to influence sarcopenia through modulating the gut–muscle axis. Emerging evidence suggests that the microbiome can regulate both skeletal muscle mass and function, in part through modulating the metabolisms of short-chain fatty acids and branch-chain amino acids that might act directly on muscle in humans or indirectly through the brain and liver. Dietary factors such as fats, proteins, and indigestible carbohydrates and lifestyle interventions such as exercise, smoking, and alcohol intake can both help and hinder the putative gut–muscle axis. The evidence presented in this review suggests that loss of muscle mass and function are not an inevitable consequence of the aging process, and that dietary and lifestyle interventions may prevent or delay sarcopenia.

show abstract

Susceptibility for Some Infectious Diseases in Patients With Diabetes: The Key Role of Glycemia

Cited by 89 publications

References 254 publications

Interplay Among the Oral Microbiome, Oral Cavity Conditions, the Host Immune Response, Diabetes Mellitus, and Its Associated-Risk Factors—An Overview

Interplay Among the Oral Microbiome, Oral Cavity Conditions, the Host Immune Response, Diabetes Mellitus, and Its Associated-Risk Factors—An Overview

Hepatic-Metabolite-Based Intermittent Fasting Enables a Sustained Reduction in Insulin Resistance in Type 2 Diabetes and Metabolic Syndrome

Sarcopenia Is a Cause and Consequence of Metabolic Dysregulation in Aging Humans: Effects of Gut Dysbiosis, Glucose Dysregulation, Diet and Lifestyle

Contact Info

Product

Resources

About